Phosphotyrosine 1062 Is Critical for the In Vivo Activity of the Ret9 Receptor Tyrosine Kinase Isoform

REFERENCES

• Airaksinen, M. S., and M. Saarma. 2002. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3:383–394.
   PubMed Web of Science ®Google Scholar
• Airaksinen, M. S., A. Titievsky, and M. Saarma. 1999. GDNF family neurotrophic factor signaling: four masters, one servant. Mol. Cell. Neurosci. 13:313–325.
   PubMed Web of Science ®Google Scholar
• Arighi, E., L. Alberti, F. Torriti, S. Ghizzoni, M. G. Rizzetti, G. Pelicci, B. Pasini, I. Bongarzone, C. Piutti, M. A. Pierotti, and M. G. Borrello. 1997. Identification of Shc docking site on Ret tyrosine kinase. Oncogene 14:773–782.
   PubMedGoogle Scholar
• Asai, N., H. Murakami, T. Iwashita, and M. Takahashi. 1996. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins. J. Biol. Chem. 271:17644–17649.
   PubMedGoogle Scholar
• Baloh, R. H., H. Enomoto, E. M. Johnson, Jr., and J. Milbrandt. 2000. The GDNF family ligands and receptors—implications for neural development. Curr. Opin. Neurobiol 10:103–110.
   PubMed Web of Science ®Google Scholar
• Besset, V., R. P. Scott, and C. F. Ibanez. 2000. Signaling complexes and protein-protein interactions involved in the activation of the ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275:39159–39166.
   PubMedGoogle Scholar
• Borrello, M. G., E. Mercalli, C. Perego, D. Degl'Innocenti, S. Ghizzoni, E. Arighi, B. Eroini, M. G. Rizzetti, and M. A. Pierotti. 2002. Differential interaction of Enigma protein with the two RET isoforms. Biochem. Biophys. Res. Commun. 296:515–522.
   PubMedGoogle Scholar
• Borrello, M. G., D. P. Smith, B. Pasini, I. Bongarzone, A. Greco, M. J. Lorenzo, E. Arighi, C. Miranda, C. Eng, L. Alberti, et al. 1995. RET activation by germline MEN2A and MEN2B mutations. Oncogene 11:2419–2427.
   PubMedGoogle Scholar
• Carrasquillo, M. M., A. S. McCallion, E. G. Puffenberger, C. S. Kashuk, N. Nouri, and A. Chakravarti. 2002. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat. Genet. 32:237–244.
   PubMed Web of Science ®Google Scholar
• Chakravarti, A. L. S. 2001. Hirschsprung's disease, p. 6231–6255. In C. R. Scriver, A. L. Beaudet, D. Valle, W. S. Sly, B. Childs, K. Kinzler, and B. Vogelstein (ed.), The metabolic and molecular bases of inherited diseases, 8th ed. McGraw-Hill, New York, N.Y.
   Google Scholar
• Degl'Innocenti, D., E. Arighi, A. Popsueva, R. Sangregorio, L. Alberti, M. G. Rizzetti, C. Ferrario, H. Sariola, M. A. Pierotti, M. G. Borrello, F. Torriti, S. Ghizzoni, G. Pelicci, B. Pasini, I. Bongarzone, and C. Piutti. 2004. Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching. Oncogene 23:7297–7309.
   PubMedGoogle Scholar
• de Graaff, E., S. Srinivas, C. Kilkenny, V. D'Agati, B. S. Mankoo, F. Costantini, and V. Pachnis. 2001. Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. Genes Dev. 15:2433–2444.
   PubMed Web of Science ®Google Scholar
• Durbec, P. L., L. B. Larsson-Blomberg, A. Schuchardt, F. Costantini, and V. Pachnis. 1996. Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development 122:349–358.
   PubMed Web of Science ®Google Scholar
• Durick, K., G. N. Gill, S. S. Taylor, and R. Y. Wu. 1998. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain. Mol. Cell. Biol. 18:2298–2308.
   PubMedGoogle Scholar
• Durick, K., R. Y. Wu, G. N. Gill, and S. S. Taylor. 1996. Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain. J. Biol. Chem. 271:12691–12694.
   PubMedGoogle Scholar
• Enomoto, H., T. Araki, A. Jackman, R. O. Heuckeroth, W. D. Snider, E. M. Johnson, Jr., and J. Milbrandt. 1998. GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 21:317–324.
   PubMed Web of Science ®Google Scholar
• Enomoto, H., P. A. Crawford, A. Gorodinsky, R. O. Heuckeroth, E. M. Johnson, Jr., and J. Milbrandt. 2001. RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development 128:3963–3974.
   PubMedGoogle Scholar
• Fukuda, T., K. Kiuchi, and M. Takahashi. 2002. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. J. Biol. Chem. 277:19114–19121.
   PubMed Web of Science ®Google Scholar
• Grimm, J., M. Sachs, S. Britsch, S. Di Cesare, T. Schwarz-Romond, K. Alitalo, and W. Birchmeier. 2001. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J. Cell Biol. 154:345–354.
   PubMedGoogle Scholar
• Hannan, A. J., R. C. Henke, R. P. Weinberger, J. W. Sentry, and P. L. Jeffrey. 1996. Differential induction and intracellular localization of SCG10 messenger RNA is associated with neuronal differentiation. Neuroscience 72:889–900.
   PubMedGoogle Scholar
• Hansford, J. R., and L. M. Mulligan. 2000. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J. Med. Genet. 37:817–827.
   PubMed Web of Science ®Google Scholar
• Hayashi, H., M. Ichihara, T. Iwashita, H. Murakami, Y. Shimono, K. Kawai, K. Kurokawa, Y. Murakumo, T. Imai, H. Funahashi, A. Nakao, and M. Takahashi. 2000. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19:4469–4475.
   PubMedGoogle Scholar
• Ichihara, M., Y. Murakumo, and M. Takahashi. 2004. RET and neuroendocrine tumors. Cancer Lett. 204:197–211.
   PubMed Web of Science ®Google Scholar
• Ishiguro, Y., T. Iwashita, H. Murakami, N. Asai, K. Iida, H. Goto, T. Hayakawa, and M. Takahashi. 1999. The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain. Endocrinology 140:3992–3998.
   PubMedGoogle Scholar
• Jhiang, S. M. 2000. The RET proto-oncogene in human cancers. Oncogene 19:5590–5597.
   PubMed Web of Science ®Google Scholar
• Jijiwa, M., T. Fukuda, K. Kawai, A. Nakamura, K. Kurokawa, Y. Murakumo, M. Ichihara, and M. Takahashi. 2004. A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia. Mol. Cell. Biol. 24:8026–8036.
   PubMed Web of Science ®Google Scholar
• Kurokawa, K., T. Iwashita, H. Murakami, H. Hayashi, K. Kawai, and M. Takahashi. 2001. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction. Oncogene 20:1929–1938.
   PubMedGoogle Scholar
• Lorenzo, M. J., G. D. Gish, C. Houghton, T. J. Stonehouse, T. Pawson, B. A. Ponder, and D. P. Smith. 1997. RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2. Oncogene 14:763–771.
   PubMedGoogle Scholar
• Margolis, B., J. P. Borg, S. Straight, and D. Meyer. 1999. The function of PTB domain proteins. Kidney Int. 56:1230–1237.
   PubMedGoogle Scholar
• Natarajan, D., C. Marcos-Gutierrez, V. Pachnis, and E. De Graaff. 2002. Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development 129:5151–5160.
   PubMed Web of Science ®Google Scholar
• Ohiwa, M., H. Murakami, T. Iwashita, N. Asai, Y. Iwata, T. Imai, H. Funahashi, H. Takagi, and M. Takahashi. 1997. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations. Biochem. Biophys. Res. Commun. 237:747–751.
   PubMedGoogle Scholar
• Pachnis, V., B. Mankoo, and F. Costantini. 1993. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005–1017.
   PubMed Web of Science ®Google Scholar
• Parisi, M. A., and R. P. Kapur. 2000. Genetics of Hirschsprung disease. Curr. Opin. Pediatr. 12:610–617.
   PubMedGoogle Scholar
• Pattyn, A., X. Morin, H. Cremer, C. Goridis, and J. F. Brunet. 1999. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399:366–370.
   PubMed Web of Science ®Google Scholar
• Ponder, B. A., and D. Smith. 1996. The MEN II syndromes and the role of the ret proto-oncogene. Adv. Cancer Res. 70:179–222.
   PubMedGoogle Scholar
• Santoro, M., F. Carlomagno, R. M. Melillo, and A. Fusco. 2004. Dysfunction of the RET receptor in human cancer. Cell. Mol. Life Sci. 61:2954–2964.
   PubMedGoogle Scholar
• Sariola, H., and M. Saarma. 2003. Novel functions and signalling pathways for GDNF. J. Cell Sci. 116:3855–3862.
   PubMed Web of Science ®Google Scholar
• Sariola, H., and K. Sainio. 1997. The tip-top branching ureter. Curr. Opin. Cell Biol. 9:877–884.
   PubMed Web of Science ®Google Scholar
• Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211–225.
   PubMed Web of Science ®Google Scholar
• Schuchardt, A., V. D'Agati, L. Larsson-Blomberg, F. Costantini, and V. Pachnis. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380–383.
   PubMed Web of Science ®Google Scholar
• Schuchardt, A., V. D'Agati, L. Larsson-Blomberg, F. Costantini, and V. Pachnis. 1995. RET-deficient mice: an animal model for Hirschsprung's disease and renal agenesis. J. Intern. Med. 238:327–332.
   PubMedGoogle Scholar
• Schuchardt, A., V. D'Agati, V. Pachnis, and F. Costantini. 1996. Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. Development 122:1919–1929.
   PubMed Web of Science ®Google Scholar
• Schuetz, G., M. Rosario, J. Grimm, T. M. Boeckers, E. D. Gundelfinger, and W. Birchmeier. 2004. The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells. J. Cell Biol. 167:945–952. (First published 29 November 2004; doi:10.1083/jcb.200404108.)
   PubMedGoogle Scholar
• Scott, R. P., S. Eketjall, H. Aineskog, and C. F. Ibanez. 2005. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase. J. Biol. Chem. 280:13442–13449. (First published 27 January 2005.)
   PubMedGoogle Scholar
• Shakya, R., T. Watanabe, and F. Costantini. 2005. The role of GDNF/Ret signaling in ureteric bud cell fate and branching morphogenesis. Dev. Cell 8:65–74.
   PubMed Web of Science ®Google Scholar
• Srinivas, S., Z. Wu, C. M. Chen, V. D'Agati, and F. Costantini. 1999. Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development. Development 126:1375–1386.
   PubMedGoogle Scholar
• Tahira, T., Y. Ishizaka, F. Itoh, T. Sugimura, and M. Nagao. 1990. Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene 5:97–102.
   PubMed Web of Science ®Google Scholar
• Takahashi, M. 2001. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 12:361–373.
   PubMed Web of Science ®Google Scholar
• Taraviras, S., C. V. Marcos-Gutierrez, P. Durbec, H. Jani, M. Grigoriou, M. Sukumaran, L. C. Wang, M. Hynes, G. Raisman, and V. Pachnis. 1999. Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126:2785–2797.
   PubMed Web of Science ®Google Scholar
• Taraviras, S., and V. Pachnis. 1999. Development of the mammalian enteric nervous system. Curr. Opin. Genet. Dev. 9:321–327.
   PubMedGoogle Scholar
• van Weering, D. H., and J. L. Bos. 1998. Signal transduction by the receptor tyrosine kinase Ret. Recent Results Cancer Res. 154:271–281.
   PubMedGoogle Scholar
• Wuenschell, C. W., N. Mori, and D. J. Anderson. 1990. Analysis of SCG10 gene expression in transgenic mice reveals that neural specificity is achieved through selective derepression. Neuron 4:595–602.
   PubMedGoogle Scholar